UBS Group AG

Position in AKAN — Akanda Corp.

CIK 1610520 ZURICH, V8

Position in AKAN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,810

+$1,223 QoQ

Shares Held

205

-59.4% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 4 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. AKAN ranks #74 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,643,241	$261,803,294
2	ELAN	Elanco Animal Health Inc	9,910,822	$243,905,327
3	UTHR	UNITED THERAPEUTICS Corp	220,616	$119,536,366
4	VTRS	Viatris Inc	6,092,296	$96,745,659
5	LNTH	Lantheus Holdings, Inc.	835,494	$92,689,703
6	HIMS	Hims & Hers Health, Inc.	2,660,810	$92,250,281
7	NBIX	Neurocrine Biosciences Inc	545,937	$92,012,220
8	TEVA	Teva Pharmaceutical Industries Ltd	2,140,065	$72,505,400

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,810	205	-91.0%	Shares	Defined	2026-08-13
2026-03-31	$1,587	2,274	-65.4%	Shares	Defined	2026-05-05
2025-12-31	$3,007	6,581	-65.8%	Shares	Defined	2026-01-29
2025-06-30	$26,940	19,243	+66.6%	Shares	Defined	2025-08-14
2025-03-31	$15,937	11,549	-22.5%	Shares	Defined	2025-05-13
2024-12-31	$23,843	14,902	-50.8%	Shares	Sole	2025-02-14
2024-03-31	$3,542	30,280	+1857.3%	Shares	Sole	2024-05-13
2023-09-30	$819	1,547	-80.5%	Shares	Sole	2023-11-09
2023-03-31	$7,699	7,938	-87.4%	Shares	Sole	2023-05-12
2022-12-31	$9,358	62,810	+553.9%	Shares	Sole	2023-02-08
2022-09-30	$4,418	9,606	+130.6%	Shares	Sole	2022-11-10
2022-06-30	$3,373	4,165	+80.1%	Shares	Sole	2022-08-10
2022-03-31	$18,357	2,312	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.